Eli Lilly and Company

Territory Business Manager - Cardiometabolic Health - Wales (East)

United Kingdom

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a proven track record in identifying and converting business opportunities into growth, demonstrating key capabilities such as effective sales calls, key account management, and business planning. Ideally, they should have experience within diabetes or weight management and be ABPI qualified.

Responsibilities

As the Territory Business Manager, responsibilities include defining and implementing a territory business plan based on local NHS and customer priorities, identifying new strategic opportunities and key healthcare influencers, delivering on ambitious new patient start goals through customer interactions, developing and maintaining deep expertise in the therapeutic area, supporting HCPs with educational strategies, and demonstrating high integrity and compliance. The role also involves working closely with Value & Access Managers, Med Ed colleagues, and key Head Office colleagues to ensure optimal patient impact and formulary access.

Skills

Account Management
Customer Insight
Account Strategy
Healthcare Industry Knowledge
Primary Care
Key Account Planning
Cross-functional Collaboration
Business Development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI